Issued Patents 2025
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421319 | Binding agents that bind OX40 (CD134) and method of use thereof to treat disease | Friederike Gieseke, Isil Altintas, David Satijn, Paul Parren | 2025-09-23 |
| 12410221 | Tumor antigens for determining cancer therapy | Claudia Paret, Kirsten Vormbrock, Christian Bender, Petra Simon, Christoph Hartmann +3 more | 2025-09-09 |
| 12410258 | Antibodies capable of binding to OX40, variants thereof and uses thereof | Kristel Kemper, Maarten van der Kroef, Dennis VERZIJL, Andrea Gorlani, Pauline L. de Goeje +5 more | 2025-09-09 |
| 12398214 | Binding agents binding to EpCAM and CD137 | Andreea Ioan, Esther BREIJ, Lars Guelen, David Satijn, Alexander Muik +6 more | 2025-08-26 |
| 12385049 | Modification of RNA, producing an increased transcript stability and translation efficiency | Silke Holtkamp, Ozlem Tureci, Sebastian Kreiter | 2025-08-12 |
| 12378531 | Use of RNA for reprogramming somatic cells | Marco Poleganov, Tim Beissert | 2025-08-05 |
| 12338448 | Trans-replicating RNA | Tim Beissert, Mario Perkovic | 2025-06-24 |
| 12291717 | RNA replicon for reprogramming somatic cells | Marco Poleganov, Mario Perkovic, Tim Beissert | 2025-05-06 |
| 12281138 | 5′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapy | Andreas Kuhn, Hiromi Muramatsu, Katalin Kariko, Stephanie Fesser | 2025-04-22 |
| 12281322 | RNA replicon for versatile and efficient gene expression | Tim Beissert, Mario Perkovic | 2025-04-22 |
| 12270813 | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy | — | 2025-04-08 |
| 12208136 | Coronavirus vaccine | Alexander Muik, Kena Anne Swanson, Qi Yang, Hui-Zhi Cai, Kayvon Modjarrad | 2025-01-28 |
| 12186387 | Coronavirus vaccine | Alexander Muik, Asaf Poran, Kena Anne Swanson, Qi Yang, Hui-Zhi Cai | 2025-01-07 |
| 12188097 | Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis | Ozlem Tureci, Daniel Maurus | 2025-01-07 |
| 12186275 | Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccination | Katharina REINHARD, Petra Simon, Karolina Anna Mroz, Kathleen HOBOHM | 2025-01-07 |